Platform
/
Dosage tracking

Your team manages the patient.
Connect remembers the dose schedule.

Not every GLP-1 patient moves up on the same timeline. Connect lets your practice define how long a treatment plan stays at each dose, tracks each patient's cycles, and advances the dose on the schedule you configured, with the provider able to override it at any time.

Track the current dose and the cycles completed at it
Hold a dose for multiple cycles
See the next planned dose and order
Override the progression at any time

Available on every Connect plan.

Where dose history lives today
Dosing spreadsheet
Note in the chart
Calendar reminder
Staff follow-up list
Where it lives in Connect
Patient record
Current dose2.5 mg
Cycles completed2 of 3
Next planned dose5 mg
Individualized timing

The dose schedule should follow the treatment plan, not your staff's memory.

Some patients may stay at an early dose for several cycles. Others may move through the treatment plan sooner. Connect keeps the configured timing attached to the patient, so your team can see where they are now and what is planned next.

Cycles at the current dose
Tirzepatide 2.5 mg
Cycle 1
Cycle 2
Cycle 3
Cycle 1 of 3
Next dose advances, override any time
Illustrative schedule

Three months at one dose. Two months at the next. Connect keeps track.

Example: a provider-configured GLP-1 plan keeps a patient at the starting dose for three monthly cycles, then moves to the next dose for two cycles. Connect counts the cycles, keeps upcoming orders visible and advances the dose when the configured point is reached. The provider can override the progression at any time.

Month 1Dose 1Cycle 1 of 3
Month 2Dose 1Cycle 2 of 3
Month 3Dose 1Cycle 3 of 3
Dose advances
Month 4Dose 2Cycle 1 of 2
Month 5Dose 2Cycle 2 of 2
Example schedule, provider configured. How long a patient should remain at a dose is a clinical decision for the licensed provider.
Set it once

Set the dosing schedule once. Let Connect track the timing.

Define the starting dose, the planned progression, the number of cycles at each dose and the maximum dose in the treatment plan. Patients enrolled on that plan inherit the schedule, and an individual patient can still be handled differently when needed.

Configure how many cycles a dose remains active.
Keep the maximum dose explicit, so the schedule stops where you tell it to stop.
Track each medication independently, with its own schedule and order cycle.
Dosage progression
On
Treatment plan
Tirzepatide — Weight program
Starting dose
2.5 mg
Cycles at starting dose
3
Cycles at next dose
2
Maximum dose
15 mg
2.5
5
7.5
10
12.5
15
Every patient enrolled on this plan inherits the schedule.
Each medication tracks independently
GLP-128-day cycle
Second medication84-day cycle
Patient · Weight program
Holding
Current dose
2.5 mg
Cycles at this dose
2 of 3
Next order
Mar 14 · 2.5 mg
Then
Apr 11 · 2.5 mg
A new month arrivesApr 11
The dose stays2.5 mg
Staying at the same dose is intentional. Billing and shipping continue on schedule.
Holds

If the patient is doing well at the current dose, keep the plan there.

A dose does not need to change just because another month arrived. When the provider's treatment plan calls for more time at the current dose, Connect can keep that dose active for additional cycles without rebuilding the program. When the configured change is due, it surfaces for review.

Hold a dose for multiple cycles.
Adjust one patient without changing everyone else on the plan.
See upcoming order strengths before they are due, and resume progression without rebuilding the plan.
Provider control

Connect advances the dose on schedule. The provider can override it at any time.

Dosage progression can be configured on medications where the dose needs to increase after each dose or after a set number of cycles. Connect shows the current dose, the next dose and where the patient sits in the treatment plan, and the provider can override the progression at any point in the patient's journey.

Override the progression at any time during the patient's journey in the plan.
An order-level override does not rewrite the whole plan.
Dose changes are recorded with the date and the user. Clinical decisions remain with the licensed provider.
Upcoming order
Tirzepatide 5 mg
Progressed from 2.5 mg · cycle 3 of 3 complete
Continue with 5 mg
Override to 2.5 mg
Recorded on the patient recordApr 11 · dose change recorded
An override applies to this order. The plan's schedule is unchanged.
Your program
Tirzepatide
2.5 mg
Next shipment
Mar 14
Next dose change
Apr 11 · 5 mg
Dose questions go to your provider in the portal.
Patient side

Give patients a clear view of where they are in the plan.

Patients can see their current dose, their next shipment and the next planned dose change in the portal. Clinical questions still route to the provider, but routine schedule questions do not have to start with the front desk.

Current dose and next planned change shown together.
Clinical questions route to the provider rather than to whoever answers the phone.
A patient who can see the plan can see where they are in it.
What the practice gets

Stop maintaining a separate GLP-1 dosing calendar.

01
Remembering who is due to change

Connect tracks cycles at the current dose and surfaces the next planned change with the order.

02
Catching wrong-strength orders

The medication order reflects the treatment-plan schedule, and the provider can override the dose before it goes out.

03
Reconstructing what happened

Dose changes are recorded on the patient record with the date and the user.

The dose history builds itself
Jan 14Dose 1 continuedHeld at dose
Feb 11Dose 1 continuedHeld at dose
Mar 14Dose 1 continuedHeld at dose
Apr 11Dose 2 activeProgression advanced
Questions

GLP-1 dosage tracking, answered

Does Connect automatically change a patient's GLP-1 dose?

Dosage progression can be configured on medications where dosages need to increase after each dose or after a certain number of cycles. Providers can override the dosage progression at any time during the patient's journey in the plan.

Can medications in the same subscription follow different dose schedules?

Yes. Each treatment plan can carry its own order cycle, dose schedule and hold rules, so a GLP-1 on a 28-day cycle and another medication on an 84-day cycle move independently inside a single subscription.

Can we keep a patient at the same dose longer?

Yes. The provider can override the progression on an order, and the treatment plan can be configured to hold doses for multiple cycles. A paused subscription does not consume a cycle.

Can a patient stay on the starting GLP-1 dose for several months?

Connect can be configured to keep a dose active for multiple treatment cycles. How long a patient should remain at a dose is a clinical decision for the licensed provider.

Which plans include dosage tracking?

Every Connect plan. Dosage tracking and dosage progression are not gated by tier, and neither is the medication catalog. Plans change your enrollee capacity, transaction rate and support level.

Connect by DrWell

Bring your GLP-1 dosing workflow. We'll build the schedule in Connect.

Show us how your practice handles dose progression today. We will configure the starting dose, the cycle timing, the holds and the planned progression, then show what the provider and the patient see when the next order comes due.

Sticky noteDosing spreadsheetCalendar reminderStep-up list
The treatment plan sets the schedule. Connect keeps track.